In the past 52-week period, shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) have moved within the range of $0.90 to $2.83. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.18, which is 22.97% higher than its 52-week high.
Second Sight Medical Products, Inc. (EYES) has demonstrated a 20-day simple moving average (SMA) of 54.56%, and a 50-day SMA of 74.33%. This public company’s current market capitalization stands at $127.70 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Second Sight Medical Products, Inc. (EYES) is Outperform.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Jun. 2017, Second Sight Medical Products, Inc. (EYES) delivered a 56.36% surprise with its net revenue.
Meanwhile, during the same quarter Second Sight Medical Products, Inc. (EYES) delivered a -20.00% earnings surprise. Net earnings for the quarter were posted at -$0.12 per share, whereas Wall Street had forecast -$0.15 per share.Ownership at Second Sight Medical Products, Inc. (EYES), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Second Sight Medical Products, Inc. (EYES) has 0 billion shares outstanding currently, 15.84% of which belong to institutional investors. Those institutional holdings amount to $0.02 billion.
Additionally, according to the most recent 13F filing from Second Sight Medical Products, Inc. (EYES), there were 10 new positions totaling 1,504,548 shares of the company’s stock. There were 9 sold out positions, on the other hand, totaling 391,528 shares.Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Second Sight Medical Products, Inc. (EYES) has had a 20-day average volume of 1,266,760 shares, with an average of 100% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 770,740 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 536,129 shares with 100% of long-term indicators pointing to Buy.